. Author manuscript; available in PMC: 2019 May 21.
Published in final edited form as:Int J Cancer. 2015 Dec 8;138(8):1851–1861. doi:
10.1002/ijc.29922 AbstractThe roles of fruits and vegetables in colorectal cancer development are unclear. Few prospective studies have assessed the association with adenoma, a known precursor to colorectal cancer. Our aim was to evaluate the association between fruit and vegetable intake and colorectal cancer development by evaluating the risk of incident and recurrent colorectal adenoma and colorectal cancer. Study participants were identified from the intervention arm of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Fruit and vegetable intake was measured using a self-reported dietary questionnaire. Total fruit and vegetable intake was not associated with reduced incident or recurrent adenoma risk overall, but a protective association was observed for multiple adenomas (Odds ratio 3rd tertile vs. 1st tertile = 0.61, 95% confidence interval (CI): 0.38, 1.00). Higher fruit and vegetable intakes were associated with a borderline reduced risk of colorectal cancer (Hazard ratio (HR) 3rd tertile vs. 1st tertile = 0.82, 95% CI: 0.67, 1.01), which reached significance amongst individuals with high processed meat intakes (HR= 0.74, 95% CI: 0.55, 0.99). Our results suggest that increased fruit and vegetable intake may protect against multiple adenoma development and may reduce the detrimental effects of high processed meat intakes on colorectal cancer risk.
Keywords: Fruits, Vegetables, Colorectal cancer, Colorectal adenoma, Diet
IntroductionFruits and vegetables are an important, natural source of a variety of vitamins, fiber and antioxidants, which have been hypothesised to reduce risk of colorectal cancer 1. However, despite a number of prospective investigations 2–12, a consensus as to whether fruit and vegetables play an active protective role against colorectal cancer has not been made. A pooled analysis of 14 cohort studies reported that fruit and vegetable intake was not strongly associated with colon cancer overall, but may be associated with distal colon cancer 13. A 2011 update of the World Cancer Research Fund/American Institute for Cancer Research colorectal cancer report suggested there is only ‘limited suggestive evidence’ for a protective role of fruit and vegetable intakes against colorectal cancer 14.
There is particular uncertainty over the stages along the adenoma-carcinoma pathway, if any, at which fruit and vegetables act. A previous publication from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial identified that individuals with the highest quartile of fruit and vegetable intake had a 25% reduced risk of prevalent adenomas 15; however, other studies of adenoma have yielded mixed results 9,16–23. Few studies of adenoma have been conducted prospectively 17,18, making recall bias a possibility, and most have had limited ability to address the potential for detection or screening bias 17. Individuals with high fruit and vegetables intakes may be more likely to engage in other healthy behaviours including attending colorectal screening, which could lead to earlier detection of adenoma 24 and a lower incidence of cancer.
We sought to further examine the temporal association between fruit and vegetable intake and the risk of incident and recurrent colorectal adenoma, and incident colorectal cancer in the intervention arm of a large prospective screening trial. Unlike many previous observational studies where opportunities for screening may be variable and thus prone to potential screening bias, in the screening arm of this trial individuals had equitable opportunities for colorectal screening and neoplasm detection.
Material and Methods Study populationStudy participants were identified from the intervention arm of the PLCO Cancer Screening Trial, described previously 25. Briefly, 154,952 individuals were recruited via ten centres in the USA (Birmingham, Alabama; Boulder, Colorado; Detroit, Michigan; Hawaii; Los Angeles, California; Minneapolis, Minnesota; Pittsburgh, Pennsylvania; Salt Lake City, Utah; St Louis, Missouri; Wisconsin; Washington, DC) between 1993 and 2001. Individuals were eligible for randomization if they were aged 55–74 years, had no history of prostate, lung, colorectal or ovarian cancer, were not undergoing cancer treatment, were not currently participating in another cancer screening or prevention trial, had not taken Finasteride in the previous six months. From 1995 onwards, individuals were not recruited if they had undergone a colonoscopy, sigmoidoscopy, barium enema or multiple prostate specific antigen tests in the previous three years. Participants were given a baseline risk factor questionnaire, which collected information on personal and family medical history, tobacco smoking habits, medication use, and anthropometry, and a food frequency questionnaire (FFQ). All participants provided written informed consent and the study was approved by the Institutional Review Boards at the National Cancer Institute and the ten recruitment centers.
A total of 77,445 participants were randomized to the screening arm of the trial. Individuals randomized to the intervention arm of the PLCO trial underwent a flexible sigmoidoscopy at baseline and at one follow-up visit, either three (T3) or five (T5) years after baseline. Individuals with abnormalities detected at screening were referred for follow-up to their usual health-care providers. Medical records from follow-up investigations were reviewed by trained personnel for relevant outcomes. Additional colorectal cancer diagnoses were ascertained through annual questionnaires and linkage to the National Death Index, confirmed via medical record review. This study was limited to individuals randomized to the intervention arm, who completed a baseline questionnaire and had no personal history of cancer (excluding non-melanoma skin cancer) (n=72,139). Additional exclusions and analytic criteria for each of the three outcomes evaluated are described below.
Colorectal cancerFor analysis of incident colorectal cancer, individuals who did not complete the Food Frequency Questionnaire (FFQ) or had an inadequate FFQ [defined as ≥8 FFQ items missing or reported extreme energy intakes (< 1st percentile or >99th percentile of intake] were excluded (n=13,495). Individuals with a history of ulcerative colitis, Crohn’s disease, polyposis or Gardner’s disease, or with cancer diagnosis prior to completion of the FFQ were also excluded from analysis (n=869). Individuals were followed up from the time of FFQ completion to the date of colorectal cancer diagnosis, death, loss to follow-up, 13 years of follow-up or 31st December 2009, whichever came first. After exclusions, 57,774 individuals remained for analysis, of whom 733 developed colorectal cancer over a median 12.1 years of follow-up.
Incident colorectal adenomaFor this analysis, only individuals who received an adequate sigmoidoscopy (defined as insertion ≥50cm with ≥90% of mucosa visible) at baseline that did not detect polyps, abnormal or suspicious findings, received an adequate sigmoidoscopy at T3/T5, and had no personal history of colorectal cancer by T3/T5 were eligible for analysis (n=22,500). Persons without evidence of polyps on both the T0 and T3/T5 screening exams were considered controls, and persons with a histologically confirmed adenoma in the distal colon or rectum detected on the T3/T5 screen, but not T0, were considered to have incident adenoma. Persons were excluded if they failed to complete the FFQ or had an inadequate FFQ (n=2,729), had a personal history of ulcerative colitis, Crohn’s disease, polyposis or Gardner’s syndrome (n=211), colorectal polyps (n=1,000), cancer, excluding non-melanoma skin cancers (n=634) or developed cancer during the trial period (n=944). After exclusions, 16,980 individuals remained for analysis, of whom 1,004 had an incident adenoma detected at either T3 or T5.
Recurrent colorectal adenomaA subset of individuals randomized to the screening arm of the trial (n=5,013) were enrolled in a secondary study of colonoscopy utilization and completed a telephone-administered questionnaire regarding all colonoscopies performed over the 10 year follow-up since the baseline sigmoidoscopy. Medical records were obtained for all endoscopy procedures and relevant medical diagnoses abstracted. The current analysis was restricted to individuals who had an adenoma diagnosed at baseline and a follow-up endoscopy within the 0.5–10 year period after baseline (n=1,905). Again, individuals who did not complete the FFQ or had an inadequate FFQ (n=147), who had a personal history of ulcerative colitis, Crohn’s disease, polyposis or Gardner’s syndrome (n=13), cancer, excluding non-melanoma skin cancers (n=76) or unknown case status (n=2) were excluded from analysis. After exclusions, 1,667 individuals for analysis, of whom 738 had a recurrent colorectal adenoma during the ten-year time period.
Exposure assessmentDietary intake of fruits and vegetables was measured using a self-administered 137-item food frequency questionnaire (FFQ), which inquired about usual dietary intake over the preceding year. The FFQ was modelled on three validated FFQs including the National Cancer Institute’s Diet History Questionnaire, the Block FFQ, and the Willett FFQ 26, but was not validated itself. Nutrient and food group values were estimated using the My Pyramid food group servings database from the U.S. Department of Agriculture 27 (Supplementary table 1).
Statistical analysisFruit and vegetable intakes were adjusted for energy using the nutrient density method 28. Energy-adjusted fruit and vegetable intakes was categorised into tertiles of intake per 1,000kcal/d, based upon the distribution of intake in the colorectal cancer cohort. Chi-squared tests (categorical variables) and ANOVA (continuous variables) were used to assess the association between baseline characteristics and outcomes. Cox proportional hazards models were used to estimate the hazard ratios (HR) and corresponding 95% confidence intervals (CI) for the association between fruit and vegetable intake and the risk of colorectal cancer. Odds ratios (OR) and 95% CIs for the association between fruit and vegetable intake and the risk of incident and recurrent adenoma were estimated using unconditional logistic regression.
Base models were developed for each outcome which included age, gender, ethnicity, study center, total energy intake (kcal/day), screening during the trial, and adenoma at baseline or follow-up screens (for colorectal cancer), trial year (T3 or T5) of screening (for incident adenoma), surveillance period and number of surveillance endoscopies (for recurrent adenoma), as covariates. To further control for possible confounders in the analysis, full models were developed for the assessment of the association between each of the main exposures (i.e., total fruit and vegetables, total fruit, total vegetables) and each outcome (i.e., incident adenoma, recurrent adenoma & colorectal cancer). For the full models, additional confounders were added to the base model if they led to ≥ 10% change in the beta coefficient for the main exposure 29. Additional factors tested in the model included education, exercise, smoking status, family history of colorectal cancer, use of non-steroidal anti-inflammatory drugs (NSAIDs), menopausal hormone therapy use (HRT), body mass index (BMI), and intakes of calcium, red meat, processed meat and alcohol. Tests for trend were assessed by assigning each individual in a particular tertile of fiber intake the median value for that tertile, prior to inclusion in the statistical model. Additional analyses were conducted with energy-adjusted intakes of fruits and vegetables modelled continuously.
Stratified analyses were conducted by age, sex, and additional confounders included in the respective further adjustment models. Interactions were tested using likelihood ratio tests comparing the models with and without the cross-product term. Additional sensitivity analyses by neoplasm location and disease severity were conducted for each of the outcomes. A two-tailed P-value < 0.05 was considered significant and analyses were conducted using Stata/SE statistical software (version 11.0, College Station, TX, USA).
Results Cohort CharacteristicsAmong the 57,774 individuals in the cohort, the median dietary intake of fruit and vegetables was 373g/d. Median energy intake was 1912kcal/d. Individuals in the highest tertile of energy-adjusted fruit and vegetable intake were more likely to be older, female, have lower BMIs, be physically active, be a HRT user and be a college graduate; and less likely to be of non-Hispanic white ethnicity, current smokers, have regularly used NSAIDs, or have a previous adenoma detected. Individuals with higher fruit and vegetable intakes also had greater calcium intakes but lower alcohol, red and processed meat intakes (Table 1).
Table 1.Baseline characteristics of participants randomized to the intervention arm of the Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial, and eligible for analysis, by tertiles of fruit and vegetable intake.
Tertiles of Total Fruit and vegetable intake (mped/1000 kcal) <1.99 (1.56a) ≥1.99, <2.80 (2.37a) ≥2.8 (3.41a) P-value Characteristics n=19,258 n=19,258 n=19,258 Age at baseline (years) 61.7 (5.0) 62.8 (5.3) 63.6 (5.4) <0.001 Male (n, %) 13,519 (70.2) 9,926 (51.5) 6,360 (33.0) <0.001 Ethnicity (n, %) Non-Hispanic White 17,603 (91.4) 17,724 (92.0) 17,149 (89.1) Non-Hispanic Black 708 (3.7) 620 (3.2) 885 (4.6) Asian 501 (2.6) 532 (2.8) 802 (4.2) <0.001 Other 446 (2.3) 382 (2.0) 422 (2.2) Education b College graduate or postgraduate (n, %) 6,255 (32.5) 7,417 (38.6) 7,149 (37.2) <0.001 Body mass index (kg/m2) 27.9 (4.8) 27.4 (4.8) 26.7 (4.8) <0.001 Physical activity, ≥4 hours/week (n, %) 3,601 (18.7) 4,402 (22.9) 5,495 (28.5) <0.001 Smoking status (n, %) b Never 5.822 (30.2) 8,389 (43.6) 10,447 (54.3) Former 3,164 (16.4) 1,521 (7.9) 988 (5.1) Current 9,277 (48.2) 8,510 (44.2) 7,263 (37.7) Pipe or cigar smoker only 992 (5.2) 931 (4.3) 557 (2.9) <0.001 Alcohol intake (g/1000 kcal) 7.3 (11.7) 4.6 (7.6) 2.8 (5.4) <0.001 Family history of colorectal cancer (n, %) 1,890 (9.8) 1,984 (10.3) 2,113 (11.0) <0.001 Adenoma at T3/T5 screen (n, %) 2,996 (15.6) 2,412 (12.5) 1,987 (10.3) Ever regular NSAID use (n, %) 12,006 (62.3) 11,942 (62.0) 11,591 (60.2) Total energy intake (kcal/d) 2,336 (886) 2,034 (729) 1,777 (659) <0.001 Total calcium intake (mg/1000 kcal) 558.3 (274.9) 641.9 (308.0) 724.2 (357.4) <0.001 Red meat intake (g/1000 kcal) 34.0 (20.5) 28.9 (17.3) 21.6 (14.6) <0.001 Processed meat intake (g/1000 kcal) 11.0 (9.7) 8.0 (7.3) 5.4 (5.8) <0.001 Hormone replacement therapy b, c 3,084 (50.8) 4,904 (52.7) 6,421 (51.0) 0.05Within the incident colorectal adenoma subset, adenoma cases were more likely to be male, of Non-Hispanic white ethnicity, current smokers, and have higher intakes of total energy, alcohol, red meat and processed meat and a higher body mass index but less likely to have higher total calcium intakes than non-cases. Within the recurrent colorectal adenoma subset, adenoma cases were more likely to be younger, male, current smokers, have a family history of colorectal cancer and have higher intakes of alcohol, and processed meat but less likely to be Non-Hispanic white or have high total calcium intakes than non-cases (Table 2).
Table 2.Baseline characteristics of cases and controls in the incident and recurrent adenoma studies.
Incident adenoma Recurrent adenoma Characteristics Cases n=1,004 Non-cases n=15,976 P-value Cases n=738 Non-cases n=929 P-value Age at baseline 62.0 (5.3) 62.2 (5.2) 0.05 63.2 (4.83) 63.0 (5.1) 0.19 Age at last follow-up screen (years) a 66.6 (5.0) 66.7 (4.9) 0.31 66.9 (5.3) 68.2 (5.4) <0.001 Male (n, %) 665 (66.2) 8,756 (54.8) <0.001 535 (72.5) 570 (62.4) <0.001 Ethnicity (n, %) Non-Hispanic White 910 (90.6) 14,181 (88.8) 689 (93.4) 887 (95.5) Non-Hispanic Black 36 (3.6) 461 (2.9) 14 (1.9) 27 (2.9) <0.001 Asian 42 (4.2) 957 (6.0) 15 (2.0) 4 (0.4) Other 16 (1.6) 377 (2.4) 0.02 20 (2.7) 11 (1.2) Education b College graduate or postgraduate (n, %) 389 (38.9) 6,266 (39.3) 0.89 283 (38.4) 325 (35.0) 0.51 Body mass index (kg/m2) 27.7 (4.7) 27.1(4.7) <0.001 27.8 (4.2) 27.5 (4.5) 0.08 Physical activity, ≥4 hours/week (n, %) 4,167 (26.1) 229 (22.8) <0.001 168 (22.8) 212 (22.8) 0.38 Smoking status (n, %)b Never 392 (39.0) 7,854 (49.2) 205 (27.8) 309 (33.3) Former 100 (10.0) 810 (5.1) 96 (13.0) 131 (14.1) Current 469 (46.7) 6,521 (40.8) 386 (52.3) 459 (49.5) Pipe or cigar smoker only 43 (4.3) 786 (4.9) <0.001 51 (6.9) 29 (3.1) <0.001 Alcohol intake (g/d) 6.3 (10.2) 4.5 (8.1) <0.001 7.4 (10.7) 6.5 (10.5) 0.05 Family history of colorectal cancer (n, %) 93 (9.3) 1,367 (8.6) 0.56 99 (13.4) 123 (13.2) 0.02 Ever regular NSAID use (n, %) 600 (59.8) 9,602 (60.1) 0.59 412 (55.8) 552 (59.4) 0.14 Total energy intake (kcal/d) 2,183 (825) 2,078 (797) <0.001 2,169 (813) 2,098 (796) 0.04 Total calcium intake (mg/1000 kcal) 576 (272) 638 (316) <0.001 537 (245) 598 (296) <0.001 Red meat intake (g/1000 kcal) 30.3 (18.7) 27.9 (18.4) <0.001 31.0 (17.7) 29.4 (18.2) 0.04 Processed meat intake (g/1000 kcal) 9.3 (8.6) 7.8 (8.6) <0.001 9.5 (8.5) 8.7 (8.0) 0.03 Incident left-sided colorectal adenomaIn base models, an inverse dose-response association was evident between incident colorectal adenoma risk and increased total fruit and vegetable intake (OR T3 v T1 0.81, 95% CI: 0.68, 0.96, Ptrend <0.07) but this association disappeared after further adjustment (OR 1.00, 95% CI: 0.83, 1.20) (Table 3). However, increasing fruit and vegetable intake continued to be associated with a reduced risk of multiple adenomas even after further adjustment (OR T3 v T1 0.61, 95% CI: 0.38, 1.00, Ptrend =0.04) (Supplementary Table 2).
Table 3.The association between fruit and vegetable intake and risk of incident adenoma in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Incident adenoma (distal colon or rectum) Distal colon a Rectal colon a Tertile cut-offs Non, cases Cases Base model b Adjusted c, d, e No. Cases Adjusted c, d, e No. Cases Adjusted c, d, e OR 95% CI OR 95% CI OR 95% CI OR 95% CI Fruit <0.79 4,975 392 1.00 ref 1.00 ref 295 1.00 ref 111 1.00 ref ≥0.79, <1.34 5,447 313 0.81 0.69, 0.95 0.93 0.79, 1.09 241 0.96 0.80, 1.16 74 0.74 0.54, 1.01 ≥1.34 5,554 299 0.85 0.72, 1.00 1.09 0.91, 1.30 234 1.10 0.90, 1.36 77 0.89 0.63, 1.25 P, trend 0.36 0.43 0.32 0.54 Fruit (excluding juice) <0.48 4,870 394 1.00 ref 1.00 ref 302 1.00 ref 105 1.00 ref ≥0.48, <0.90 5,507 326 0.82 0.70, 0.96 0.94 0.80, 1.10 247 0.93 0.77, 1.11 87 0.89 0.66, 1.21 ≥0.9 5,599 284 0.78 0.65, 0.92 0.98 0.82, 1.18 221 0.99 0.81, 1.22 70 0.84 0.59, 1.20 P, trend 0.03 0.90 0.99 0.36 Vegetables <1.06 5,101 350 1.00 ref 1.00 ref 271 1.00 ref 87 1.00 ref ≥1.06, <1.47 5,407 363 1.06 0.91, 1.24 1.13 0.97, 1.33 280 1.12 0.94, 1.34 91 1.13 0.83, 1.54 ≥1.47 5,468 291 0.95 0.80, 1.13 1.06 0.89, 1.26 219 1.02 0.84, 1.25 84 1.21 0.87, 1.68 P, trend 0.35 0.54 0.86 0.26 Fruit & Vegetables <1.99 4,922 397 1.00 ref 1.00 ref 306 1.00 ref 107 1.00 ref ≥1.99, <2.80 5,513 321 0.82 0.70, 0.96 0.92 0.78, 1.08 249 0.92 0.77, 1.11 82 0.82 0.60, 1.11 ≥2.8 5,541 286 0.81 0.68, 0.96 1.00 0.83, 1.20 215 0.96 0.78, 1.18 73 0.86 0.61, 1.22 P, trend 0.07 0.98 0.71 0.41 Fruit & vegetables (excluding juice) <1.64 4,954 378 1.00 ref 1.00 ref 294 1.00 ref 93 1.00 ref ≥1.64, <2.36 5,448 337 0.91 0.77, 1.06 1.02 0.87, 1.20 259 1.00 0.84, 1.20 91 1.08 0.80, 1.48 ≥2.36 5,574 289 0.87 0.73, 1.04 1.07 0.89, 1.29 217 1.01 0.82, 1.25 78 1.13 0.79, 1.61 P, trend 0.12 0.48 0.90 0.51Results for incident adenoma were similar when fruit and vegetable variables were analysed as continuous variables (data not shown).
No significant interactions were observed with gender, smoking, BMI, or processed meat intake (Pinteraction > 0.05; Supplementary Tables 3 & 4).
Recurrent colorectal adenomaSimilar to incident adenoma, there were no significant associations between fruit and vegetable intake and recurrent adenoma risk with or without adjustment for potential confounders (OR total fruits and vegetables T3 v T1 0.87, 95% CI: 0.64, 1.20, P trend=0.40). Results for incident adenoma were similar when fruit and vegetable variables were analysed as continuous variables (data not shown). Stratified analyses by adenoma location (Table 4) and advanced adenoma status (data not shown) also yielded null results.
Table 4.The association between fruit and vegetable intake and the risk of recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Any recurrent adenoma (any at baseline) Recurrent adenoma in colon a Recurrent adenoma in distal colon a Recurrent adenoma in proximal colon a Recurrent adenoma in rectum a Tertile cut-offs Non-cases Cases Base model b Adjusted c, d, e No. Cases Adjusted c, d, e No. Cases Adjusted c, d, e No. Cases Adjusted c, d, e No. Cases Adjusted c, d, e HR 95% CI HR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI Fruit <0.79 349 299 1.00 ref 1.00 ref 259 1.00 ref 121 1.00 ref 177 1.00 ref 28 1.00 ref ≥0.79–<1.34 295 264 1.03 0.78, 1.35 1.05 0.79, 1.38 248 1.12 0.84, 1.49 114 1.12 0.77, 1.62 171 1.16 0.84, 1.61 26 0.96 0.49, 1.88 ≥1.34 285 175 0.90 0.67, 1.22 0.93 0.68, 1.28 156 0.96 0.69, 1.33 77 0.97 0.63, 1.49 112 0.99 0.68, 1.44 24 1.12 0.54–2.33 P-trend 0.49 0.66 0.78 0.88 0.96 0.74 Fruit (excluding juice) <0.48 344 285 1.00 ref 1.00 ref 247 1.00 ref 114 1.00 ref 168 1.00 ref 25 1.00 ref ≥0.48–<0.90 294 267 1.21 0.92, 1.64 1.25 0.94, 1.66 248 1.32 0.99, 1.78 117 1.32 0.90, 1.93 169 1.32 0.95, 1.84 29 1.43 0.73–2.81 ≥0.9 291 186 0.91 0.67, 1.24 0.96 0.70, 1.32 168 0.97 0.69, 1.35 81 0.94 0.60, 1.46 123 1.06 0.73, 1.54 24 1.17 0.55–2.52 P-trend 0.49 0.67 0.92 0.84 0.47 0.99 Vegetables <1.06 318 265 1.00 ref 1.00 ref 232 1.00 ref 110 1.00 ref 164 1.00 ref 29 1.00 ref ≥1.06–<1.47 327 249 0.95 0.73, 1.25 0.95 0.72, 1.24 220 0.92 0.69, 1.22 98 0.87 0.60, 1.27 159 0.97 0.70, 1.33 19 0.60 0.30, 1.18 ≥1.47 284 224 0.94 0.70, 1.25 0.93 0.69, 1.25 211 0.98 0.72, 1.33 104 1.08 0.73, 1.61 137 0.89 0.63, 1.27 30 0.89 0.46, 1.74 P-trend 0.67 0.63 0.90 0.66 0.52 0.84 Fruit & Vegetables <1.99 351 306 1.00 ref 1.00 ref 265 1.00 ref 122 1.00 ref 182 1.00 ref 27 1.00 ref ≥1.99–<2.80 301 250 1.00 0.76, 1.31 0.99 0.75, 1.31 232 1.05 0.78, 1.40 107 1.08 0.74, 1.57 169 1.14 0.83, 1.58 26 0.95 0.48, 1.87 ≥2.8 277 182 0.87 0.64, 1.19 0.87 0.64, 1.20 166 0.91 0.66, 1.27 83 1.02 0.66, 1.56 109 0.85 0.59, 1.24 25 1.15 0.56–2.37 P-trend 0.39 0.40 0.59 0.94 0.41 0.68 Fruit & vegetables (excluding juice) <1.64 347 284 1.00 ref 1.00 ref 246 1.00 ref 119 1.00 ref 162 1.00 ref 26 1.00 ref ≥1.64–<2.36 309 254 1.02 0.78, 1.34 1.03 0.78, 1.36 236 1.09 0.82, 1.45 107 0.98 0.68, 1.42 173 1.27 0.92, 1.76 25 0.82 0.42, 1.63 ≥2.36 273 200 1.01 0.75, 1.36 1.03 0.75, 1.40 181 1.05 0.76, 1.45 86 1.00 0.66, 1.52 125 1.12 0.77, 1.62 27 1.13 0.56–2.29 P-trend 0.96 0.88 0.77 0.99 0.59 0.64 Incident colorectal cancerIn base models, a significantly reduced risk of colorectal cancer was observed for individuals with higher total fruit and vegetable intakes (HR T3 v T1=0.77, 95% CI: 0.63, 0.94, Ptrend = 0.01), which became attenuated after further adjustment (HR T3 v T1=0.82, 95% CI: 0.67, 1.01, Ptrend = 0.05) (Table 5). Results were similar were similar when fruit and vegetable variables were analysed as continuous variables (data not shown). No differences were observed by cancer location with all showing weak, non-significant associations. No significant differences were observed by stage (data not shown), age, or gender (Supplementary Table 5). Interestingly, although the p-value for interactions were not significant, the protective association for total fruit and vegetable intake appeared stronger among those with intakes of processed meats above the median (HR =0.74, 95% CI: 0.55, 0.99, Ptrend=0.07) compared to those with intakes below median (HR=0.90, 95% CI: 0.66, 1.21; Pinteraction=0.42) and for ever smokers (HR=0.74, 95% CI: 0.61–1.03, Ptrend=0.07) compared to never smokers (HR=0.90, 95% CI: 0.64–1.25; Pinteraction=0.15) (Supplementary Table 6).
Table 5.The association between fruit and vegetable intake and risk of colorectal cancer in the Prostate, Lung, Colorectal And Ovarian (PLCO) Cancer Screening Trial.
Colorectal cancer (all) Colon cancer Distal colon cancer Proximal colon cancer Rectal cancer Tertile cut-offs Follow-up time No. Cases Base model a Adjusted b, c, d No. Cases Adjusted b, c, d No. Cases Adjusted b, c, d No. Cases Adjusted b, c, d No. Cases Adjusted b, c, d HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI Fruit (including juice) <0.79 212,704 244 1.00 ref 1.00 ref 183 1.00 ref 51 1.00 ref 132 1.00 ref 57 1.00 ref ≤0.79–<1.34 216,113 262 1.02 0.86, 1.23 1.10 0.92, 1.32 204 1.08 0.87, 1.32 52 1.02 0.69, 1.52 152 1.10 0.86, 1.40 53 1.20 0.81, 1.77 >1.34 215,489 227 0.88 0.73, 1.07 1.00 0.82, 1.22 183 0.99 0.79, 1.25 52 1.03 0.67, 1.59 131 0.97 0.74, 1.27 42 1.11 0.71, 1.72 P-trend 0.18 0.93 0.87 0.88 0.74 0.67 Fruit (excluding juice) <0.48 211,399 258 1.00 ref 1.00 ref 192 1.00 ref 52 1.00 ref 140 1.00 ref 62 1.00 ref ≤0.48–<0.90 216,310 257 0.94 0.79, 1.13 1.01 0.84, 1.20 196 0.98 0.79, 1.20 55 1.04 0.70, 1.54 141 0.95 0.75, 1.22 56 1.14 0.78, 1.66 >0.9 216,598 218 0.78 0.65, 0.95 0.87 0.71, 1.07 182 0.90 0.72, 1.13 48 0.93 0.60, 1.43 134 0.89 0.68, 1.16 34 0.79 0.50, 1.27 P-trend 0.01 0.16 0.36 0.69 0.39 0.33 Vegetables <1.06 212,341 279 1.00 ref 1.00 ref 211 1.00 ref 64 1.00 ref 147 1.00 ref 64 1.00 ref ≤1.06–<1.47 216,065 222 0.80 0.67, 0.95 0.81 0.68, 0.97 179 0.84 0.69, 1.03 45 0.72 0.49, 1.07 134 0.89 0.70, 1.13 41 0.70 0.47, 1.04 >1.47 215,900 232 0.83 0.69, 0.99 0.85 0.71, 1.03 180 0.85 0.69, 1.04 46 0.73 0.49, 1.09 134 0.90 0.70, 1.15 47 0.86 0.58, 1.28 P-trend 0.06 0.11 0.14 0.13 0.4 0.47 Fruit & Vegetables (including juice) <1.99 212,520 264 1.00 ref 1.00 ref 201 1.00 ref 56 1.00 ref 145 1.00 ref 60 1.00 ref ≤1.99–<2.80 215,790 256 0.94 0.79, 1.12 0.97 0.81, 1.16 199 0.95 0.77, 1.16 53 0.94 0.64, 1.39 146 0.95 0.75, 1.21 53 1.06 0.72, 1.55 >2.8 215,997 213 0.77 0.63, 0.94 0.82 0.67, 1.01 170 0.80 0.64, 1.01 46 0.80 0.52, 1.24 124 0.80 0.61, 1.04 39 0.87 0.55, 1.36 P-trend 0.01 0.05 0.06 0.32 0.09 0.54 Fruit & vegetables (excluding juice) <1.64 211,747 268 1.00 ref 1.00 ref 200 1.00 ref 59 1.00 ref 141 1.00 ref 65 1.00 ref ≤1.64–<2.36 216,254 242 0.87 0.73, 1.04 0.90 0.75, 1.08 192 0.92 0.75, 1.12 51 0.85 0.58, 1.25 141 0.94 0.74, 1.20 46 0.83 0.56, 1.22 >2.36 216,306 223 0.79 0.65, 0.96 0.84 0.69, 1.02 178 0.84 0.67, 1.05 45 0.74 0.48, 1.13 133 0.88 0.68, 1.15 41 0.82 0.53, 1.26 P-trend 0.02 0.09 0.13 0.16 0.35 0.36 Types of fruit and vegetableWhen analysed by type of fruit or vegetable consumed, a reduction in incident adenoma risk was noted in the base model amongst the highest consumers of ‘other fruits’, which includes solid fruits not within the citrus, berry and melon category (HR=0.77, 95% CI: 0.65, 0.91) (Supplementary Table 7) and moderate consumers of orange vegetables (HR=0.84, 95% CI: 0.72, 0.99) (Supplementary Table 8); however, these associations disappeared after further adjustment for other covariates. An increased risk was observed amongst individuals with the highest intakes of ‘other vegetables’, which includes vegetables not within the dark-green, orange or starch vegetable categories. No significant associations were observed for any type of fruit or vegetable for recurrent adenoma. High intake of citrus fruits, melons and berries was associated with a reduced risk of colorectal cancer (HR=0.79, 95% CI: 0.65, 0.95, Ptrend=0.01); however, the association was no longer statistically significant after full adjustment (HR=0.85, 95% CI: 0.70, 1.03, Ptrend=0.09). There were no statistically significant associations between any types of fruit or vegetable and risk of colon or rectal cancer after adjustment (data not shown).
DiscussionOverall, the results of this large prospective cohort of screened individuals suggest that fruit and vegetable intakes are not associated with risk of incident or recurrent adenoma; however, high fruit and vegetable intakes may be associated with a reduced risk of multiple adenomas and colorectal cancer.
Previous studies of fruits and vegetables and adenoma have yielded mixed results 9,15–18. Of those studies that have examined the association prospectively 17,18, only the Nurse’s Health study examined fruit and vegetable intake in relation to incident adenoma, where cases and controls were adenoma-free in a previous endoscopy, and this study did find an inverse association between high fruit intake and incident adenoma detection at a later screen 17. Unlike in our study, not all participants in the Nurses’ Health Study received endoscopy as part of routine screening and the likelihood of adenoma detection may have differed based on the reason for endoscopy. High fruit and vegetable consumers may seek screening more readily 24, so may be more likely to attend without symptoms, whereas low fruit and vegetable consumers may wait until symptoms develop before attending screening. Therefore, the evidence regarding a role of fruits and vegetables in adenoma development is mixed and may require further study.
Despite the lack of association with adenoma overall, we did see a protective association for total fruit and vegetable intake and the risk of multiple adenomas. This finding should be viewed cautiously due to the number of sub-group comparisons. Nevertheless, the association suggests that if high fruit and vegetable intake is protective for colorectal cancer, it may offer protection by reducing the number of adenomas and therefore, the likelihood that any one polyp will progress to cancer.
The lack of an association between fruit and vegetable intakes and risk of adenoma recurrence is consistent with previous results from the Polyp Prevention Trial, which found that randomisation to receive intensive counselling promoting a diet high in fruits, vegetables and fiber but low in fat did not reduce risk of adenoma recurrence compared to maintaining their current diet (Relative Risk = 0.98, 95% CI: 0.88, 1.09) 30. It should be noted, however, dietary interventions may be require a longer time interval in order for their effects to be seen.
The World Cancer Research Fund/American Institute of Cancer Research continuous update report 31 concluded that there was only ‘limited suggestive’ evidence regarding an association between fruit and vegetable intakes and colorectal cancer risk based on a lack of evidence indicating a linear association 32. Nevertheless, another systematic review conducted at a similar time did find a significant non-linear association between fruit and vegetable intakes and colorectal cancer risk 33 and the magnitude of the association is in line with those of the current study. Therefore, the lack of statistical significance in the current study could be attributable to insufficient statistical power to detect a relatively modest association.
Despite the lack of significance overall, there was an association between total fruit and vegetable intakes and risk of colorectal cancer amongst individuals with higher processed meat intakes. Processed meat consumption is thought to increase risk of colorectal cancer via production of carcinogenic N-nitroso compounds upon consumption 34,35. Whilst this sub-group analysis should be interpreted with caution, it is biologically plausible and consistent with interactions observed for other gastrointestinal cancers 36. Experimental studies indicate that vitamin C and other polyphenols found in fruits and vegetables may inhibit nitrosamine formation 37 and dietary fiber, also found in fruits and vegetables, may reduce colonic exposure to carcinogens through dilution or reduced transit time 38. This novel finding therefore warrants further investigation.
In regards to individual types of fruits and vegetables, there were no associations with risk of colorectal, colon or rectal cancer after full adjustment, which is largely consistent with existing literature 4,7,39. Only ‘other’ vegetables, i.e. not within the dark-green, orange or starch vegetable categories (Supplementary table 1), were associated with risk of incident or recurrent adenoma. It is difficult to speculate on a shared biological mechanism by which this heterogeneous vegetable group would impact on adenoma development, and improved classification would be required in future studies to explore this further.
Our study had a number of strengths and weaknesses. In addition to the minimisation of detection bias for the adenoma outcomes, the prospective study design prevents the possibility of recall bias. The study also had robust data on a variety of potential confounders including smoking, BMI, physical activity and other dietary factors, allowing for multivariate adjustment. The use of the same source population for all of the outcomes allowed for a comprehensive evaluation of associations across the adenoma-carcinoma development pathway without the heterogeneity of multiple base populations. However, as flexible sigmoidoscopy only assesses the distal (left-sided) colon and rectum, proximal adenoma could not be evaluated and the results for distal or rectal adenoma may not be generalizable to proximal adenoma. Dietary assessment is also complex and food frequency questionnaires are not an ideal measure of habitual dietary intakes, so intakes of fruits and vegetables may have been underestimated, due to problems with recall 41. Whilst the misreporting is likely non-differential between groups, the ability to detect associations may have been reduced.
In conclusion, this prospective study, where all individuals underwent the same colorectal screening protocol, did not find evidence that high fruit and vegetable intakes are associated with a reduced risk of colorectal adenoma. The role of fruits and vegetables in risk of colorectal cancer remains unclear but our results suggest they may neutralise the detrimental effects of high processed meat intakes on colorectal carcinogenesis. Further studies are needed to examine the interaction between fruits and vegetables and processed meats on colorectal neoplasm risk.
Supplementary Material8
Novelty and impact of work.This novel study uses data from the screening arm of the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial to investigate the association between fruit and vegetable intakes and risk of incident and recurrent adenoma and incident colorectal cancer. Uniquely, this allowed the examination of incident adenoma risk with minimal detection bias, as all individuals were screened for adenoma at baseline, and had equitable opportunities for colorectal screening and neoplasm detection at a later screen.
AcknowledgmentsThis work was supported in part by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, United states Department of Health and Human Services.
AbbreviationsHazard ratio
Confidence interva
Odds ratio
World Cancer Research Fund
American Institute for Cancer Research
European Prospective Investigation into Cancer and Nutrition
Food frequency questionnaire
Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial
Body mass index
Non-steroidal anti-inflammatory drug
Hormone replacement therapy
Baseline
3 years after baseline
5 years after baseline
The authors report no conflicts of interest.
The Prostate, Lung, Colorectal, Ovarian Cancer Screening trial was registered at https://clinicaltrials.gov as NCT01696981.
ReferencesThis section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials8
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3